Skip to main content

Walgreens January Sales Increase 11.3 Percent

Walgreens (NYSE: WAG) (NASDAQ: WAG) had January sales of $5.93 billion, an increase of 11.3 percent from $5.33 billion for the same month in 2010. Duane Reade stores, acquired in April 2010, contributed 2.8 percentage points to the total sales increase for the month.

Sales in comparable stores (those open at least a year) increased 6.1 percent. The effect of calendar day shifts positively impacted total comparable sales by 0.7 percentage point. Duane Reade stores are not included in any comparable store results.

Total front-end sales increased 11.5 percent in January, including 4.7 percentage points from Duane Reade stores. Comparable store front-end sales increased 4.5 percent. Customer traffic in comparable stores increased 2.4 percent, while basket size increased 2.1 percent.

January pharmacy sales increased 10.8 percent, while comparable pharmacy sales increased 6.9 percent. The effect of calendar day shifts positively impacted comparable pharmacy sales by 1.1 percentage points. Comparable pharmacy sales were negatively impacted by 2.9 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 66.1 percent of total sales for the month.

Prescriptions filled at comparable stores increased 6.3 percent in January. Calendar day shifts positively impacted prescriptions filled in comparable stores by 1.1 percentage points, while the higher incidence of flu positively impacted comparable prescriptions filled by 1.6 percentage points. Prescriptions filled at comparable stores were negatively impacted by 1.3 percentage points due to fewer flu shots.

Flu shots administered season-to-date at pharmacies and clinics totaled more than 6.3 million.

Fiscal 2011 year-to-date sales for the first five months were $30.1 billion, up 7.3 percent from $28 billion in the comparable period in fiscal 2010.

Walgreens opened 13 stores during January, including two relocations, acquired three stores and closed one.

At Jan. 31, Walgreens operated 8,146 locations in all 50 states, the District of Columbia, Puerto Rico and Guam. That includes 7,670 drugstores, 506 more than a year ago, including 297 stores acquired over the last 12 months. The company also operates worksite health centers, home care facilities, and specialty and mail service pharmacies. Its Take Care Health Systems subsidiary manages more than 700 in-store convenient care clinics and worksite health and wellness centers. Franchisees of Option Care, Inc., a wholly-owned subsidiary of Walgreens, are not included in Walgreens location or store count.

January Comparable Sales and Prescriptions Filled
Calendar Shift Generics Cough, Cold, Flu Flu shot
ReportedImpactImpactImpactImpact
Total Comp Sales 6.1% 0.7% -1.9% 0.6% -0.3%
Comp Front End 4.5% - -
Comp Rx Sales 6.9% 1.1% -2.9% 0.9% -0.4%
Comp Rx Scripts 6.3%* 1.1% - 1.6% -1.3%
* Includes +1.1% from patients filling more 90-day prescriptions

Please note: Sales numbers and the adjustments shown in the table are preliminary and unaudited. Comparable stores are defined as those drugstore locations open for at least 12 consecutive months without closure for seven or more consecutive days and without a major remodel or a natural disaster in the past 12 months. Acquired operating locations, including Duane Reade stores and relocations are not included as comparable stores for the first 12 months after the acquisition or relocation.

Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, the incidence of flu and the number of flu shots administered as well as those described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each of which is incorporated herein by reference, and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, Walgreens undertakes no obligation to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

Contacts:

Walgreens
Media Contact:
Tiffani Washington, 224-723-3440
or
Investor Contacts:
Rick Hans, CFA, 847-315-2385
Lisa Meers, CFA, 847-315-2361
http://news.walgreens.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.